Fibrinolysis after application of a pneumatic tourniquet
- PMID: 3124428
Fibrinolysis after application of a pneumatic tourniquet
Abstract
The fibrinolytic system was studied after application of a pneumatic tourniquet in 22 patients undergoing elective orthopaedic surgery and during 20-min venous occlusion in 17 healthy subjects. Blood was sampled before anaesthesia (A), before operation (B) and after operation from the ipsilateral (C) and the contralateral (D) limb. Tissue plasminogen activator (t-PA) activity, t-PA antigen and t-PA activity/t-PA antigen ratio increased by, respectively, 557, 109 and 168% in the C samples as compared with A blood (all differences statistically significant). The t-PA activity and t-PA antigen increased slightly in the systemic circulation (B and D) but were significantly less in C than after venous occlusion. Fast-acting inhibitor of t-PA increased significantly in C (15%). During compression with a pneumatic tourniquet, mainly local fibrinolytic activation occurs, and this activation partly explains the low incidence of postoperative deep venous thrombosis after use of a tourniquet.
Similar articles
-
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.Thromb Haemost. 1988 Dec 22;60(3):361-4. Thromb Haemost. 1988. PMID: 3149043
-
Prospective double-arm study of fibrinolysis in surgical patients.J Surg Res. 1998 Jan;74(1):96-101. doi: 10.1006/jsre.1997.5233. J Surg Res. 1998. PMID: 9536981 Clinical Trial.
-
Fibrinolytic activity in peripheral atherosclerosis in the elderly.Thromb Haemost. 1999 Feb;81(2):275-80. Thromb Haemost. 1999. PMID: 10064006
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
-
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.J Cell Biochem. 1987 Feb;33(2):77-86. doi: 10.1002/jcb.240330202. J Cell Biochem. 1987. PMID: 3553213 Review.
Cited by
-
Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus.Hip Pelvis. 2017 Jun;29(2):81-90. doi: 10.5371/hp.2017.29.2.81. Epub 2017 Jun 2. Hip Pelvis. 2017. PMID: 28611958 Free PMC article. Review.
-
A comparative analysis of the role of Tranexamic acid as an independent variable in reducing intraoperative blood loss in patients undergoing conventional total knee arthroplasty versus computer-assisted total knee arthroplasty.Musculoskelet Surg. 2017 Dec;101(3):255-259. doi: 10.1007/s12306-017-0477-9. Epub 2017 May 3. Musculoskelet Surg. 2017. PMID: 28470576 Clinical Trial.
-
Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage.Indian J Orthop. 2011 Mar;45(2):148-52. doi: 10.4103/0019-5413.77135. Indian J Orthop. 2011. PMID: 21430870 Free PMC article.
-
Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence.J Blood Med. 2015 Aug 25;6:239-44. doi: 10.2147/JBM.S61915. eCollection 2015. J Blood Med. 2015. PMID: 26345147 Free PMC article. Review.
-
Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty.Knee Surg Sports Traumatol Arthrosc. 2012 Dec;20(12):2494-501. doi: 10.1007/s00167-012-1942-5. Epub 2012 Mar 15. Knee Surg Sports Traumatol Arthrosc. 2012. PMID: 22419263 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical